Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report overviewing the trends driving the offshoring of clinical trials.
Offshoring Clinical Trials: The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel reports that offshoring of clinical trials is increasing as companies in the U.S. are finding challenges in clinical trial research ranging from cost, patient recruitment, patient compliance during participation, qualified professionals and new clinical trial patients.
The authors of the report note that countries such as India and China have a vast population who are interested in taking part in clinical trial research, and these regions can often produce the required number of participants in half the time, with better compliance and less costly medical professionals. They further note that Brazil and Mexico are increasingly important region, and Israel has emerged as a player in this market.
For each country profiled, the report includes the following information:
- Total Clinical Trials Revenues for Country
- Number of Clinical Trials for Each Country
- Clinical Trials Markets by Major City
- Breakdown of Trials by Disease Category for each Country and Major Cities
- Market Drivers and Inhibitors for each country.
- Population and Disease statistics.
- Profiles of Key Companies operating in that Country
The study combines extensive secondary research into the clinical trials markets with interviews with market leaders. The authors have conducted interviews with more than 30 key industry officials, consultants, health care providers, and government personnel.
Report Buyer product ID: KAL00100
Report Buyer Category: Pharma & Healthcare
